What is the nearest airport to your company?

First Shanghai Airport, welcome to visit us.

Purity 99% Bulk Adenosine Disodium Triphosphate Powder Raw Material

Name: Purity 99% Bulk Adenosine Disodium Triphosphate Powder Raw Material
Brand: Anhui GSH Bio-Technology Co., Ltd.
SKU: 1946981101

Anhui, ChinaAnhui GSH Bio-Technology Co., Ltd.

US$66.00-70.00

25 kg

Sample price:US$0.00/bag.Request sample

Product profile

Customization

Available

CAS No.

987-65-5

Formula

C10h14n5na2o13p3

Model NO.

Adenosine disodium triphosphate

Appearance

Powder

Colour

White

Shape

Powder

Certification

ISO9001, FDA, Halal, Kosher, HACCP, Fssc22000

Storage Condition

Store in Cool Place Away From Sunlight

Assay

98.0%-101.0%

Transport Package

1kg/Bag, 25kg/Drum

Specification

>98%

Trademark

GST

Origin

Anhui

HS Code

29349990

Production Capacity

900tons/Year

Key features

High Purity Raw Material: Purity 99% with assay 98.0%-101.0%, suitable for supplements and beverages.

Multiple Certifications: Certified by ISO9001, FDA, Halal, Kosher, HACCP, and Fssc22000.

OEM/ODM Service: Supports logo printing and full customization from samples or designs.

Wide Application: Used for heart failure, myocardial infarction, and as energy source for muscles.

Free Sample Available: Provides free samples for quality verification, buyer pays shipping.

Professional Manufacturer: Established in 2017 with 128 employees and 20 R&D engineers.

Strict Quality Control: 100% inspection for finished products with 16 QA/QC inspectors.

Fast Delivery: Average lead time within 15 workdays for both peak and off seasons.

Company profile

Importers and ExportersHigh Repeat Buyers Choice100% Finished Products InspectionManagement Certification

Anhui GSH Bio-Technology Co., Ltd.

Anhui, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤1.95h

AI-Powered supplier vetting

SummaryAnhui Gute Biotechnology Co., Ltd., also identified as Anhui GSH Bio-Technology Co., Ltd., is a China-based manufacturing company established in 2017. It reports three production lines, production bases in Jilin and Anhui, a third base planned for construction in 2023, 20 years of combined R&D engineer experience, and 21–30 quality-control staff. Its listed products include glutathione, NMN, citicoline sodium, CoQ10, and related ingredients, with stated output for several products. The supplier reports ISO9001:2015 and applications for BRCGS, HALAL, KOSHER, FSSC, HACCP, and FDA-related certifications. An SGS audit record is valid from June 20, 2025 to June 19, 2026, but the provided audit result value is not interpretable as a performance conclusion. Overseas service, detailed R&D services, customization, sustainability systems, and customer cases remain insufficiently evidenced.

Supplier typeThe supplier is explicitly identified as a factory and manufacturing enterprise in Anhui, China, with production bases in Anhui and Jilin and an integrated R&D, production, and sales model. This supports classification as a direct manufacturer rather than a trading-only entity.

CertificationsThe supplier explicitly reports an ISO9001:2015 certificate and lists applications for BRCGS, HALAL, KOSHER, FSSC, HACCP, and FDA-related certificates. An SGS audit record is also shown as valid from June 20, 2025 to June 19, 2026, although the supplied audit result value does not establish the audit outcome.

R&D capabilityThe supplier describes integrated R&D, production, and sales, 14 years of R&D experience, 19 declared Chinese invention patents, 2 declared international invention patents, 7 authorized Chinese invention patents, and 8 software copyrights. Nevertheless, specific professional-technical R&D, 3D design, SDK, new-product, and ODM capabilities are marked unknown.

Production capacityThe supplier reports three production lines, major production bases in Jilin and Anhui, a third base planned to begin construction in April 2023, and product output figures for citicoline sodium, glutathione, and NMN. These records provide explicit evidence of established production capacity and multi-site operations.